Get started
Author

Niko Thio

Observed name: N. Thio
ORCID: 0000-0002-3089-0871
Observed ORCID: 0000-0002-3089-0871
OpenAlex ID: A5018538945
The molecular origin and taxonomy of mucinous ovarian carcinoma
2019 · Dane Cheasley, Matthew J. Wakefield, et al. · Nature Communications · 191
PDF
T STEM -like CAR-T cells exhibit improved persistence and tumor control compared with conventional CAR-T cells in preclinical models
2023 · Deborah Meyran, Joe Jiang Zhu, et al. · Science Translational Medicine · 106
Therapeutic options for mucinous ovarian carcinoma
2020 · Kylie L. Gorringe, Dane Cheasley, et al. · Gynecologic Oncology · 92
PDF
The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma
2020 · Tanjina Kader, Kenneth Elder, et al. · npj Breast Cancer · 33
PDF
Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma
2019 · Tanjina Kader, Prue Hill, et al. · The Journal of Pathology · 29
PDF
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary
2022 · Atara Posner, Owen WJ Prall, et al. · The Journal of Pathology · 28
PDF
Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment
2022 · Angela Pizzolla, Simon Paul Keam, et al. · Journal for ImmunoTherapy of Cancer · 26
PDF
Inhibition of mutant IDH1 promotes cycling of acute myeloid leukemia stem cells
2022 · Emily Gruber, Joan So, et al. · Cell Reports · 25
Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects
2021 · Na Li, Magnus Zethoven, et al. · npj Breast Cancer · 23
PDF
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors
2020 · Christopher R. McEvoy, Holly Holliday, et al. · Laboratory Investigation · 22
PDF
Caspase-2 protects against ferroptotic cell death
2024 · Swati Dawar, Mariana C. Benitez, et al. · Cell Death and Disease · 21
PDF
Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary
2023 · Atara Posner, Tharani Sivakumaran, et al. · Journal for ImmunoTherapy of Cancer · 18
PDF
Identification of resistance mechanisms to small-molecule inhibition of TEAD-regulated transcription
2024 · Aishwarya Kulkarni, Varshini Mohan, et al. · EMBO Reports · 15
Web Service Recommendation Based on Client-Side Performance Estimation
2007 · Niko Thio, Shanika Karunasekera · Proceedings - Australian Software Engineering Conference/Proceedings · 15
A NUT carcinoma lacking squamous differentiation and expressing TTF1
2021 · Owen W.J. Prall, Niko Thio, et al. · Pathology · 14
PDF
Three-dimensional CRISPR screening reveals epigenetic interaction with anti-angiogenic therapy
2021 · Michael Y. He, Michael M. Halford, et al. · Communications Biology · 11
PDF
Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer
2022 · Carlos S. Cabalag, Owen W. J. Prall, et al. · Annals of Surgical Oncology · 10
PDF
Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer
2025 · Carmelo Cerra, Madeleine R. C. Tancock, et al. · Cell Death Discovery · 5
PDF
126 Early-phenotype Lewis Y CAR-T cells persist better in vivo and induce solid tumor regression in combination with anti-PD1
2020 · Deborah Meyran, Joe Zhu, et al. · Regular and Young Investigator Award Abstracts · 5
MicroRNA profiling in aplastic anemia reveals similarities between secondary myelodysplastic syndromes arising from clonal progression and de novo MDS
2023 · Lynette Chee, Rachel Koldej, et al. · Frontiers in Hematology · 4
PDF
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma
2024 · Olivia Craig, Samuel Lee, et al. · NAR Genomics and Bioinformatics · 3
Tumor-resident T cells and dendritic cells form an in situ archetype during immunotherapy response in melanoma
2026 · Andrea Di Pietro, Lewis Au, et al. · Nature Communications · 2
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials
2026 · Alexander D. Sherry, Van To, et al. · European Urology · 2
Abstract A006: Tissue resident memory (TRM) T cells and dendritic cells form an in situ archetype for improved response to immune checkpoint therapy in metastatic melanoma
2024 · Andrea Di Pietro, Lewis Au, et al. · Cancer Immunology Research · 2
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma
2026 · Van To, Niko Thio, et al. · Nature Communications · 1
Works count: 49
Citation count: 704
H-index: 14
I10-index: 17
Year
Topic
Type